SARS-CoV-2 Vaccine-Induced Seroconversion and Immune Correlates in Patients with Hematological Malignancies. A Real World Study.

Saved in:

Bibliographic Details
Title:	SARS-CoV-2 Vaccine-Induced Seroconversion and Immune Correlates in Patients with Hematological Malignancies. A Real World Study.
Authors:	Nass N; Department of Internal Medicine 1, Dessau Medical Centre and Brandenburg Medical School Theodor-Fontane, Dessau, 06847, Germany.; Institute of Pathology, Medical School Brandenburg Theodor-Fontane, University Hospital Brandenburg/Havel, Brandenburg, 14770, Germany., Yaakoub MK; Department of Internal Medicine 1, Dessau Medical Centre and Brandenburg Medical School Theodor-Fontane, Dessau, 06847, Germany., Simion AV; Institute of Clinical Chemistry, Dessau Medical Centre and Brandenburg Medical School Theodor-Fontane, Dessau, 06847, Germany., Kroll H; Institute for Transfusion Medicine Dessau, Red Cross Blood Transfusion Service NSTOB, Dessau, 06847, Germany., Westphal S; Institute of Clinical Chemistry, Dessau Medical Centre and Brandenburg Medical School Theodor-Fontane, Dessau, 06847, Germany., Pannier J; Department of Internal Medicine 1, Dessau Medical Centre and Brandenburg Medical School Theodor-Fontane, Dessau, 06847, Germany., Behre G; Department of Internal Medicine 1, Dessau Medical Centre and Brandenburg Medical School Theodor-Fontane, Dessau, 06847, Germany.
Source:	Oncology research [Oncol Res] 2025 Sep 26; Vol. 33 (10), pp. 2923-2935. Date of Electronic Publication: 2025 Sep 26 (Print Publication: 2025).
Publication Type:	Journal Article
Journal Info:	Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1555-3906
DOI:	10.32604/or.2025.067561